Sanofi India Ltd. Hits 52-Week High

Sanofi India Ltd., a midcap pharmaceutical company, has recently hit a 52-week high on January 2nd, 2024. The stock has been performing well in the market, with a 'Hold' recommendation from MarketsMOJO. On January 2nd, the stock reached a new high of Rs. 8349, showing a 3.82% increase in the last 3 days. It has also been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The pharma sector as a whole has also seen a gain of 2.32%. One of the notable features of Sanofi India Ltd. is its high dividend yield of 4.65% at the current price. This makes it an attractive option for investors looking for stable returns. In terms of performance, Sanofi India Ltd. has outperformed the Sensex by a significant margin, with a 1-year return of 42.22% compared to the Sensex's 17.53%. This showcases the company's strong growth and potential in the market. Sanofi India Ltd. is a midcap company in the pharmaceutical industry, known for its quality products and strong financials. With its recent surge in stock price and positive market sentiment, it is definitely a company to watch out for in the coming days.